Summit Global Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$18.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$17.9M |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$9.92M |
| 4 |
Hershey
HSY
|
+$8.28M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$11.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$11.4M |
| 3 |
Incyte
INCY
|
+$9.85M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.36M |
| 5 |
Best Buy
BBY
|
+$8.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.73% |
| 2 | Healthcare | 12.12% |
| 3 | Financials | 9.32% |
| 4 | Consumer Staples | 9.11% |
| 5 | Consumer Discretionary | 7.59% |
Similar funds
Summit Global Investments's Q4 2021 Portfolio in Review
As of Q4 2021, Summit Global Investments held 660 positions worth $1.56B, up 17% from $1.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Summit Global Investments deployed $107M of net new capital in Q4 2021, opening 197 new positions and adding to 199 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Intuit, an estimated $11.9M trimmed.
- Summit Global Investments's largest Q4 2021 buy was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
- Summit Global Investments added most to Bristol-Myers Squibb in Q4 2021, an estimated $17.9M increase.
- Summit Global Investments's biggest Q4 2021 reduction was Intuit, cutting an estimated $11.9M.
- Summit Global Investments fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $11.4M.
- Summit Global Investments's ten largest holdings make up 24% of its $1.56B portfolio in Q4 2021.
- Summit Global Investments opened 197 new positions and closed 124 in Q4 2021.
- Summit Global Investments's portfolio value rose 17% quarter-over-quarter to $1.56B.
Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.